Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Pfizer La Jolla
Sale #156: Pfizer La Jolla Biotech Facility Relocation: Mass Spectrometers, HPLC Systems, Chromatography, Freezers & More! San Diego, CA

Starting: Apr 7th, 2026 7:00am PDT

Ending: Apr 8th, 2026 9:00am PDT

Immediately Accepting Bids
Cytiva
Sale #2: Cytiva Surplus of Lab & Facility Equipment: Freezers, Centrifuges, Biosafety Cabinets, Forklifts & More! Marlborough, MA.

Starting: Mar 23rd, 2026 7:00am EDT

Ending: Mar 24th, 2026 12:00pm EDT

Immediately Accepting Bids
Immunitas Therapeutics PSS
Biotech & Pharmaceutical Lab Equipment: Mass Specs, GCMS, UPLC, LCMS, ICP-OES, FTIR Systems & More! Multiple Locations, US

Starting: Mar 9th, 2026 7:00am PDT

Ending: Mar 10th, 2026 9:00am PDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.